FDA grants traditional approval for LEQEMBI® (lecanemab-irmb) for the treatment of Alzheimer’s disease
Stockholm, July 7, 2023 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the U.S. Food and Drug Administration, FDA, has approved the supplemental Biologics License Application, sBLA, supporting the traditional approval of LEQEMBI® (lecanemab-irmb) 100 mg/mL injection for intravenous use, making LEQEMBI the first and only approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional decline in adults with Alzheimer’s disease (AD). In conjunction with the approval the Centers for Medicare and Medicaid Services, CMS,
“It Peels So Good” global campaign showcases significance of the Chiquita BrandFort Lauderdale, FL – July 6 2023 – Chiquita , the leading banana company, recently announced the launch of its new global campaign, “It Peels So Good.” The campaign reinforces Chiquita’s leadership role in the banana category while celebrating the brand’s premium quality, delicious taste, distinctive personality, and iconic heritage.
“It Peels So Good” tells the story of a banana company with a rich history and a bright future. With the assonance of "peel" and "feel," the campaign
